TCT-73 A Systematic review and meta-analysis of emergency coronary angiography and percutaneous coronary intervention in patients who present with cardiac arrest. Should we implement a standard invasive approach?  by Sjauw, Krischan D. et al.
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comTCT-73
A Systematic review and meta-analysis of emergency coronary angiography and
percutaneous coronary intervention in patients who present with cardiac arrest.
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Background: Because of limited data, the indications and timing of coronary
angiography (CAG) and percutaneous coronary intervention (PCI) in patients
with cardiac arrest are controversial. In clinical practice it is often difﬁcult to
determine which patients beneﬁt from early catheterization, with subsequent
PCI. The guidelines promote early catheterization in cardiac arrest patients
with ST-elevation myocardial infarction. However, the predictive value of the
ECG for coronary artery occlusion is poor, especially after cardiopulmonary
resuscitation.
Methods: Medical literature databases were scrutinized to identify randomized trials
comparing CAG vs. no CAG, and PCI vs. no PCI. In absence of randomized trials
cohort studies evaluating emergency CAG and PCI in cardiac arrest were identiﬁed.
Two separate meta-analyses were performed respectively.
Results: The ﬁrst meta-analysis included 16 cohort studies of patients with cardiac
arrest (n¼7709). Early CAG compared to no CAG was associated with an absolute
decrease of in-hospital mortality of 14% [95% conﬁdence interval (CI), 12–16%;
P< 0.0001]. This survival beneﬁt was also observed in subsequent subgroup analysis,
respectively of patients with STEMI or new LBBB, and patients with other ECG
patterns. The second meta-analysis included 11 cohort studies evaluating the effect of
emergency PCI in cardiac arrest patients (n¼3033). Emergency PCI compared to no
PCI was associated with an absolute decrease of in-hospital mortality of 18% [95% CI
14-22%; P< 0.0001].
Conclusions: Both early CAG and PCI, compared to respectively no CAG and PCI
were associated with a survival beneﬁt in patients presenting with cardiac arrest.
This did not differ between patients with STEMI or new LBBB, and patients with
other ECG patterns. The prevalence of coronary heart disease, regardless of pre-
senting ECG pattern, is high. All available observational data evaluating early
CAG and PCI is importantly hampered by bias and confounding; i.e. survival and
physician selection bias. Nonetheless, the results of this study support further
evaluation of a more a more aggressive CAG and PCI strategy than currently
advocated.
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Background: The efﬁcacy of Impella (Abiomed Inc., MA, USA) for electrical insta-
bility in the setting of an acute ST-elevation myocardial infarction (STEMI) isB22 JACC Vol 64/11/Suppl Bunknown. Herein, we present a case series of successful hemodynamic support and
electrical stabilization by an Impella device in the setting of ischemic cardiogenic shock.
Methods: Both patients received guideline-directed medical therapy for
STEMI and support with aggressive ﬂuid resuscitation, intubation and inotropes.
Intra-aortic balloon pump and Impella devices were inserted through the femoral
approach.
Results: A 67-year-old female suffered an acute inferior STEMI with cardiogenic
shock from severe right heart failure. During revascularization, she developed
multiple episodes of ventricular tachycardia (VT)-ﬁbrillation (VF) despite amio-
darone infusion. In light of her hemodynamic and electrical cardiac instability, an
intra-aortic balloon pump (IABP) was inserted. However, she remained in right
ventricular (RV) shock (cardiac index of 1.8 L/min/m2) and required a total of 27
deﬁbrillations. A decision was made to insert an Impella 2.5 as a bridge to RV re-
covery, with dramatic hemodynamic and electrical response. Device was success-
fully removed the following day and she recovered well. A 52 year old male was
admitted in cardiogenic shock secondary to an anterior wall STEMI. Cardiac cath-
eterization revealed a complete occlusion of the left anterior descending coronary
artery. The patient received an IABP due to hemodynamic instability. He subse-
quently required more than 20 deﬁbrillations for VT/VF. The IABP was replaced by
an Impella 2.5 device. The patient was quickly restored to sinus rhythm after Impella
in place. The device was removed 4 days after the procedure and the patient
recovered well.
Conclusions: We report two cases of severe electrical instability with recurrent VT/
VF in the setting of cardiogenic shock secondary to an acute myocardial infarction.
In this limited experience, the Impella left ventricular assist device was able to
achieve electrical stability more effectively when compared to an intra-aortic
balloon pump.Heart Failure Therapies
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Complete revascularization in ischemic heart failure may improve patient
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Background: Heart failure (HF) is the major cause of death in cardiovascular disease,
with coronary artery disease (CAD) remaining its most common cause. STICH trial
has left us with many questions unanswered and most PCI-related trials exclude
subjects with ejection fraction (EF) < 35%. Complete coronary revascularization is
one of key concepts in management of ischemic HF.
Methods: We have retrospectively analyzed 1078 unselected patients with
systolic HF (EF< 35%) hospitalized between 2009-2012. Among them we have
selected a group of non-ACS pts scheduled for coronary angiography (n¼495).
57 CABG-qualiﬁed subjects were excluded from analysis. Pts were divided into
group A (complete revascularization, n¼221) and group B (incomplete revas-
cularization, n¼217). Complete revascularization was assessed angiographic-
ally, deﬁned according to current ESC guidelines (vessels >2mm). Patients
were in 12-month follow-up for rehospitalisation, myocardial infarction and
mortality.
Results: Patient characteristics are presented in table 1. Patients in group A had higher
prevalence or prior PCI (54,3 vs 38,2%, p¼0,001), with no differences in prior CAGB
(20,8 vs 22,1%, p¼ns). The incidence of multi-vessel disease was signiﬁcantly higher
in group B (32,4 vs 68,1%, p< 0,01). There have been no signiﬁcant differences in
PCI strategy in both groups. In follow up 12-month mortality was signiﬁcantly lower
in pts with complete revascularization (10,4 vs 18,43%, p¼0,01). The composite
endpoint of death or MI was also signiﬁcantly in favor of complete revascularization
(11,7 vs 23,5%, p¼0,01).
Conclusions: Our study shows, that in an unselected ischemic HF population complete
revascularization has led to improved survival. If possible, complete revascularization in
HF should be considered, and should be one of the factors determining the selection of
revascularization method, with PCI emerging as a safe and viable option.j September 13–17, 2014 j TCT Abstracts/Heart Failure Therapies
